EIC Accelerator 2026
Scale-up funding for high-impact innovation. Next published full-proposal cut-off: 4 November 2026.
Potential fit if Disease Intelligence meets EIC technology, SME and readiness requirements.Official EIC source ↗DISEASE INTELLIGENCE · FUNDING & SCALE OSBuild the company.
Build the company.
Prove the engine. Fund the scale.
Disease Intelligence V9 adds a funding-readiness layer to the product: grant radar, investor room, validation architecture, defensibility, consortium building, benchmark design and a staged scale roadmap. The goal is not to claim we are already the world's strongest platform—it is to build the evidence required to earn that position.
FUNDING READINESS
Funders do not finance feature lists. They finance credible de-risking.
V9 turns the company story into a sequence of testable claims: technical novelty, data defensibility, customer need, regulatory boundary, measurable outcomes, scalable economics and an execution team.
01
Readiness Score
Assess what is evidenced and what is still a funding risk.
Score the company →02Validation Lab
Define technical, workflow, economic, trust and safety validation gates.
Build the evidence →03Defensibility
Show why this is more than an LLM wrapper or directory.
Inspect the moat →04Scale Roadmap
Translate funding into milestones investors and grant evaluators can audit.
See the roadmap →CURRENT FUNDING RADAR · VERIFIED 11 SEP 2026
Separate immediate opportunities from future-stage capital.
Eligibility always depends on the applicant entity, TRL, ownership, project scope, state-aid position and call rules. The radar links to official sources instead of presenting funding as guaranteed.
Xjenza Malta P2M
Up to €30,000 to move from prototype toward MVP and early market traction. 2026 cut-offs include end of September.
Potential early-stage product/market-validation route subject to programme eligibility.Official Xjenza source ↗Digital Vouchers 2026
Data Readiness and Build vouchers can reach €20,000; TARF/MDIA Sandbox support can reach €25,000.
Useful for data readiness, API-standard data work and regulatory/sandbox preparation.Official Xjenza source ↗EIC Pre-Accelerator
Malta is an eligible widening country. The 2027 call is planned for grants of €500k–€1m, opening 5 May 2027 with deadline 18 November 2027.
Potential route for an eligible deep-tech SME at approximately TRL 4–6.Official EIC source ↗INVESTOR-GRADE STORY
What has to be true for Disease Intelligence to become globally defensible?
Not “we use AI.” The funding case should be built around a governed healthcare intelligence graph, verifiable capability data, evidence provenance, workflow distribution, interoperable infrastructure, network effects and proprietary aggregate insight.
Graph moatDisease ↔ capability ↔ institution ↔ evidence ↔ research ↔ access
Workflow moatRouting, referrals, verification, collections, signals and institutional operating workflows
Trust moatProvenance, freshness, conflicts, consent, permissions and auditability
Network moatPatients, physicians, hospitals, researchers, life sciences and public-sector participants increase utility for others